Literature DB >> 10215283

Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.

A Celentano1, F P Mancini, M Crivaro, V Palmieri, L A Ferrara, V De Stefano, G Di Minno, G de Simone.   

Abstract

We investigated the influence of major cardiovascular risk factors (smoking, hypercholesterolemia, diabetes mellitus) on the association between angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism and echocardiographic left ventricular mass in 225 patients with sustained hypertension, assessed by ambulatory blood pressure monitoring. When the study population was analyzed as a whole, the 3 ACE genotypes did not differ in left ventricular mass (II, 47 g/m2.7; ID, 49 g/m2.7; DD, 51 g/m2.7; p = NS). No difference was found in subjects (n = 135) in whom at least 1 major cardiovascular risk factor was present (II, 51 g/m2.7; ID, 51 g/m2.7; DD: 52 g/m2.7; p = NS). In contrast, in the absence of cardiovascular risk factors, DD subjects (n = 32) exhibited left ventricular mass index higher than non-DD (ID/II) subjects (n = 75; p <0.05). After controlling for age and sex, in the absence of cardiovascular risk factors, the risk of left ventricular hypertrophy was 3.8-fold higher in DD than in non-DD patients (odds ratio 3.8; 95% confidence interval 1.2 to 12.1, p <0.02). We conclude that in the present setting of patients with established sustained systemic hypertension, the absence of risk factors potentially affecting cardiovascular adaptation allows for the detection of a positive association between homozygosity for the D allele of the ACE gene and left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215283     DOI: 10.1016/s0002-9149(99)00058-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.

Authors:  Xiaobo Li; Yuqiong Li; Nan Jia; Shujie Guo; Shaoli Chu; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-07-07       Impact factor: 2.316

Review 2.  [ACE gene polymorphism and cardiovascular diseases].

Authors:  B Mayer; H Schunkert
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

Review 3.  [The various forms of left ventricular hypertrophy: diagnostic value of echocardiography].

Authors:  F Weidemann; S Störk; S Herrmann; G Ertl; M Niemann
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

4.  Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.

Authors:  Ramachandran S Vasan; Nicole L Glazer; Janine F Felix; Wolfgang Lieb; Philipp S Wild; Stephan B Felix; Norbert Watzinger; Martin G Larson; Nicholas L Smith; Abbas Dehghan; Anika Grosshennig; Arne Schillert; Alexander Teumer; Reinhold Schmidt; Sekar Kathiresan; Thomas Lumley; Yurii S Aulchenko; Inke R König; Tanja Zeller; Georg Homuth; Maksim Struchalin; Jayashri Aragam; Joshua C Bis; Fernando Rivadeneira; Jeanette Erdmann; Renate B Schnabel; Marcus Dörr; Robert Zweiker; Lars Lind; Richard J Rodeheffer; Karin Halina Greiser; Daniel Levy; Talin Haritunians; Jaap W Deckers; Jan Stritzke; Karl J Lackner; Uwe Völker; Erik Ingelsson; Iftikhar Kullo; Johannes Haerting; Christopher J O'Donnell; Susan R Heckbert; Bruno H Stricker; Andreas Ziegler; Thorsten Reffelmann; Margaret M Redfield; Karl Werdan; Gary F Mitchell; Kenneth Rice; Donna K Arnett; Albert Hofman; John S Gottdiener; Andre G Uitterlinden; Thomas Meitinger; Maria Blettner; Nele Friedrich; Thomas J Wang; Bruce M Psaty; Cornelia M van Duijn; H-Erich Wichmann; Thomas F Munzel; Heyo K Kroemer; Emelia J Benjamin; Jerome I Rotter; Jacqueline C Witteman; Heribert Schunkert; Helena Schmidt; Henry Völzke; Stefan Blankenberg
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

5.  Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China.

Authors:  Fang Yuan; Lu-Shun Zhang; Hong-Yu Li; Miao Liao; Meili Lv; Chongjie Zhang
Journal:  DNA Cell Biol       Date:  2013-04-09       Impact factor: 3.311

6.  Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.

Authors:  Ehsan Bahramali; Mona Rajabi; Javad Jamshidi; Seyyed Mohammad Mousavi; Mehrdad Zarghami; Alireza Manafi; Negar Firouzabadi
Journal:  BMJ Open       Date:  2016-02-09       Impact factor: 2.692

Review 7.  Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics.

Authors:  Chayakrit Krittanawong; Tao Sun; Eyal Herzog
Journal:  Curr Cardiol Rev       Date:  2017

8.  Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Martin G Larson; Jayashri Aragam; Thomas J Wang; Gary F Mitchell; Sekar Kathiresan; Christopher Newton-Cheh; Joseph A Vita; Michelle J Keyes; Christopher J O'Donnell; Daniel Levy; Emelia J Benjamin
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

9.  ACE gene dosage determines additional autonomic dysfunction and increases renal angiotensin II levels in diabetic mice.

Authors:  Oscar Albuquerque de Moraes; Karin Flues; Kátia Bilhar Scapini; Cristiano Mostarda; Fabiana de Sant'Anna Evangelista; Bruno Rodrigues; Daniela Ravizzoni Dartora; Patricia Fiorino; Kátia De Angelis; Maria Cláudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2018-08-02       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.